Trial reportInternational urogynecology journal2010
Minimum 2-year follow-up of mid-urethral slings, effect on quality of life, incontinence impact and sexual function.
Trial report in International urogynecology journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.
- Autologous Slings in Female Stress Urinary Incontinence Treatment: Systematic Review and Meta-Analysis of Randomized Controlled Trials.International urogynecology journal · 2024Pooled it
- Traditional suburethral sling operations for urinary incontinence in women.The Cochrane database of systematic reviews · 2020Pooled it
- TVT versus TOT, 2-year prospective randomized study.World journal of urology · 2013Trial
- Pelvic floor symptoms improve similarly after pessary and behavioral treatment for stress incontinence.Female pelvic medicine & reconstructive surgeryTrial
- Reporting and grading of complications after mid-urethral sling surgeries: Could the "Clavien-Dindo Classification" be adopted?Current urology · 2021Article
- Impact of transobturator vaginal tape on female stress urinary incontinence and sexual function.Arab journal of urology · 2017Article
- A Meta-Analysis Detailing Overall Sexual Function and Orgasmic Function in Women Undergoing Midurethral Sling Surgery for Stress Incontinence.Sexual medicine · 2017Review
- Safety considerations for synthetic sling surgery.Nature reviews. Urology · 2015Review
- Sexual function and quality of life following retropubic TVT and single-incision sling in women with stress urinary incontinence: results of a prospective study.Archives of gynecology and obstetrics · 2013Article
- Mesh complications in female pelvic floor reconstructive surgery and their management: A systematic review.Indian journal of urology : IJU : journal of the Urological Society of India · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisIn this study, the impact of mid-urethral slings (MUS) on incontinence-related distress, quality of life and sexual function is assessed at a minimum 2 years.
methodsPatients received either a pubovaginal sling (PVS) or a tension-free vaginal tape (TVT). The Arabic translation of urogenital distress inventory (UDI)-6, incontinence impact questionnaire (IIQ)-7, and short form Female Sexual Function Index (FSFI) were administered at baseline and 24 months.
resultsSixty three women with a mean age of 47.8 years were included in this study. A median follow-up was done after 54 ± 21.9 months. Thirty nine women had PVS while 24 had TVT. Cure was defined as a significant decrease in UDI-6 and a negative stress test at 200 ml, which was found to be 93.65% and 95.2%, respectively. Overall, UDI-6 decreased from a mean preoperative value of 68.1 ± 16.9 to 27.6 ± 18.3 (p < 0.0001). IIQ-7 decreased from 70 ± 19 to 24 ± 20.8(p < 0.0001). The difference between pre- and postoperative values was insignificant.
conclusionAn MUS gives a cure rate of over 93% at a median follow-up of 54 months. A significant decline in UDI-6 and IIQ-7 is evident after surgery. Sexual function, as measured by the FSFI, was not significantly affected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.